DDrare: Database of Drug Development for Rare Diseases

57. 特発性拡張型心筋症
［臨床試験数：12，薬物数：25（DrugBank：12），標的遺伝子数：9，標的パスウェイ数：33］

Searched query = "Idiopathic dilated cardiomyopathy"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Drug = 18F-deoxyglucose (FDG); Allopurinol; Benazepril; Carvedilol; Coenzyme Q10; Dobutamine; Doxazosin; GRANOCYTE - 34 million IU (Lenograstim rHuG-CSF); Granocyte; Granocyte Lenograstim; Granulocyte Colony Stimulating Factor; Granulocyte colony stimulating factor (GCSF); HTEA; Honey; Infusion of autologous mononuclear bone marrow cells; Lenograstim; Metoprolol; Metoprolol succinate; Metoprolol succinate + doxazosin; Mono Nuclear Cell (MNC) transplantation; PL 12185/0002 & PL 12185/0005(WATER FOR INJECTION); Procedure: bone marrow mononuclear cells; Umbilical cord mesenchymal stem cells; Valsartan; Water

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02292043 (ClinicalTrials.gov)	May 2013	31/10/2014	Effects of HTEA ON Heart Failure Secondary to Idiopathic Dilated Cardiomyopathy or Post-myocardial Infarction	Effects of HTEA ON Heart Failure Secondary to Idiopathic Dilated Cardiomyopathy or Post-myocardial Infarction	Congestive Heart Failure	Drug: HTEA	Harbin Medical University	NULL	Recruiting	20 Years	80 Years	Both	60	N/A	China

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

NCT02292043
(ClinicalTrials.gov)

May 2013

31/10/2014

Effects of HTEA ON Heart Failure Secondary to Idiopathic Dilated Cardiomyopathy or Post-myocardial Infarction

Congestive Heart Failure

Drug: HTEA

Harbin Medical University

NULL

Recruiting

20 Years

80 Years

Both

N/A

China